Current therapy of hepatitis C
Publisher
Springer Netherlands
Reference18 articles.
1. Jäeckel E, Cornberg M, Wiedemeyer H et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001;345:1452–7.
2. Veldt B, Saracco G, Boyer N et al. Long-term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut. 2004;53:1504–8.
3. Veldt B, Hansen B, Eijkemans M et al. Dynamic decision analysis to determine optimal treatment duration in chronic hepatitis C. Aliment Pharmacol Ther. 2005;21:539–47.
4. Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958–65.
5. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975–82.